Egalet Ltd.
Clinical Trials
20
Trial Phases
3 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (20 trials with phase data)• Click on a phase to view related trials
Efficacy and Safety of Egalet-002 in Patients With Moderate-to-Severe Chronic Low Back Pain
- Conditions
- Moderate-to-severe Chronic Low Back Pain
- Interventions
- Drug: Placebo of oxycodone extended-release
- First Posted Date
- 2016-03-23
- Last Posted Date
- 2018-03-05
- Lead Sponsor
- Egalet Ltd
- Target Recruit Count
- 549
- Registration Number
- NCT02716857
- Locations
- 🇺🇸
Site 207, Birmingham, Alabama, United States
🇺🇸Site 202, Mobile, Alabama, United States
🇺🇸Site 253, Phoenix, Arizona, United States
Safety and Tolerability of Egalet-002 in Patients With Moderate-to-Severe Chronic Noncancer Pain
- Conditions
- Moderate-to-severe Chronic Noncancer Pain
- Interventions
- First Posted Date
- 2015-11-13
- Last Posted Date
- 2018-03-05
- Lead Sponsor
- Egalet Ltd
- Target Recruit Count
- 281
- Registration Number
- NCT02603705
- Locations
- 🇺🇸
Site 334, Huntsville, Alabama, United States
🇺🇸Site 328, Tucson, Arizona, United States
🇺🇸Site 332, Jacksonville, Florida, United States
SPRIX in 0 to 11 Year-Old Patients Undergoing Open Surgical Procedures
- First Posted Date
- 2014-04-03
- Last Posted Date
- 2017-03-17
- Lead Sponsor
- Egalet Ltd
- Target Recruit Count
- 45
- Registration Number
- NCT02102516
- Locations
- 🇵🇱
Instytut "Centrum Zdrowia Matki Polki" (Institute "Mother's Memorial Hospital"), Lodz, Poland
🇵🇱Klinika Chirurgii i Traumatologii Dzieciecej - Dzieciecy Szpital Kliniczny im. prof. Antoniego Gebali, Lublin, Poland
🇵🇱Regional Hospital of Ludwika Rydygiera in Torun, Torun, Poland
Study to Assess the Absorption and Tolerability of Intranasal Ketorolac Tromethamine and to Assess the Effects of Oxymetazoline Hydrochloride and Fluticasone Propionate on the Absorption and Tolerability of Intranasal Ketorolac Tromethamine in Participants With Allergic Rhinitis
- Conditions
- Allergic Rhinitis
- Interventions
- First Posted Date
- 2011-06-03
- Last Posted Date
- 2018-03-06
- Lead Sponsor
- Egalet Ltd
- Target Recruit Count
- 24
- Registration Number
- NCT01365650
- Locations
- 🇦🇺
Pain and Anaesthesia Research Clinic/Royal Adelaide Hospital, Adelaide, Australia
Open Label Study to Assess the Pharmacokinetics of Intranasal Ketorolac Tromethamine Following Fluticasone Propionate in Healthy Subjects
- Conditions
- Healthy Subjects
- Interventions
- First Posted Date
- 2011-06-03
- Last Posted Date
- 2017-03-15
- Lead Sponsor
- Egalet Ltd
- Target Recruit Count
- 36
- Registration Number
- NCT01365611
- Locations
- 🇬🇧
ICON Development Solutions, Manchester, United Kingdom
- Prev
- 1
- 2
- 3
- 4
- Next